Jefferies Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Jefferies Group’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-219,200	Closed	-$373K	–	2824
2018 Q3	$373K	Hold	219,200	–	–	﹤0.01%	1764
2018 Q2	$381K	Hold	219,200	–	–	﹤0.01%	1733
2018 Q1	$401K	Buy	+219,200	New	+$463K	﹤0.01%	1624

Other funds holding SGYP

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Jefferies Group's SGYP Position: Q1 2019 in Review

Jefferies Group sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 1,711,837 shares — an estimated $195K sold.

Jefferies Group first reported a position in SGYP in Q2 2015 and held it in 6 quarters. The position peaked at $307K in Q3 2018. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

Jefferies Group reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
Jefferies Group sold 1,711,837 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $195K.
Jefferies Group first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and held it in 6 quarters.
Jefferies Group's Synergy Pharmaceuticals, Inc Common Stock position peaked at $307K in Q3 2018.
12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Jefferies Group's 13F filing for Q1 2019, filed 15 May 2019.